STAT

SEPTEMBER 15, 2023

The latest goal for the end of polio transmission will almost certainly not be met, according to a frank and concerning report about the future of the decades-long polio eradication effort that was released this week. After having missed multiple deadlines for ending polio transmission, the Global Polio Eradication Initiative had set 2023 as the year when both wild polio viruses would finally be snuffed out and so-called vaccine-derived viruses would also be stopped, putting an end to a family o

Vaccines 355

Vaccines 355

ALiEM - Pharm Pearls

SEPTEMBER 15, 2023

A 64-year-old Caucasian male with a history of alcohol use disorder and tobacco use disorder presents with painless bilateral hand contractures that have been worsening for the past several months. He denies any recent trauma, fever, chills, or decreased sensation. The patient works as a construction worker. Physical Exam Vitals : BP 143/83 ; HR 94; RR 18; T 98.6°F; O2 saturation 98% on room air Musculoskeletal : He has bilateral palmar contractures proximal to the fourth digits.

Diabetes 150

Diabetes Clinic Management 150

STAT

SEPTEMBER 15, 2023

In order to provide gender-affirming care, clinicians must sometimes jump through unusual hoops. In Australia, for example, the government won’t subsidize testosterone treatment for a trans man without a peculiar bureaucratic maneuver; a doctor must say the patient has a testicular disorder. The disorder: Trans men, being trans, are born without testes.

348

348

PharmaVoice

SEPTEMBER 15, 2023

Forecasts from the biggest pharma companies follow a pattern of thinking big and manifesting the desired outcome.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

SEPTEMBER 15, 2023

There is just not enough Wegovy. The current manufacturing shortage will eventually end, and those who have health insurance that covers Wegovy, plus the even luckier ones who can afford to pay out of pocket, will once again get their medication.

322

322

LifeProNow

SEPTEMBER 15, 2023

Job interviews can be nerve-wracking, but one question that you can almost guarantee will come up is, “Why are you changing jobs?” While it may seem like a straightforward query, crafting a thoughtful and convincing response can significantly impact the outcome of your interview. In this blog post, we’ll explore how to answer this common interview question effectively. 1.

100

100

The Pharmacist

SEPTEMBER 15, 2023

Health minister Neil O’Brien has agreed to meet with community pharmacy stakeholders following a debate in parliament which centred on the significant challenges across the sector. The debate held yesterday was called by Conservative MP for Waveney Peter Aldous to highlight the role that community pharmacies play and to address the ‘enormous pressures’ they currently […] The post Health minister agrees to meet with pharmacy stakeholders appeared first on The Pharmacist.

Community Pharmacies 122

Community Pharmacies 122

STAT

SEPTEMBER 15, 2023

South African authorities are investigating Johnson & Johnson and its Janssen subsidiary over “excessive pricing” of a lifesaving tuberculosis drug, the latest imbroglio to engulf the company of its medicine. In a brief statement , the South African Competition Commission confirmed that it lodged a complaint earlier this week against the health care giant over its TB medicine, bedaquiline , which is also sold under the Sirturo brand name.

Drug Pricing 271

Drug Pricing 271

Pharmafile

SEPTEMBER 15, 2023

GSK and Save the Children have announced that they will be renewing their partnership for an additional five years. GSK plans to invest £15m in the partnership, with the two companies working together to increase rates of childhood vaccination. The partnership aims to reduce the number of ‘zero dose’ children in Ethiopia and Nigeria, meaning […] The post GSK and Save the Children extend partnership for unvaccinated children appeared first on Pharmafile.

Vaccines 118

Vaccines 118

STAT

SEPTEMBER 15, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them.  Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

224

224

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

European Pharmaceutical Review

SEPTEMBER 15, 2023

The CBL-0201DD Phase II study evaluating the first-in-class small-molecule drug CBL-514 for Dercum’s disease, a rare disorder, has demonstrated significant efficacy in reducing lipoma size and complete clearance. Dercum’s disease is characterised by painful lipomas developing primarily on the trunk in the body. Currently there are no approved or effective medicine, so the data from the Phase II study shows potential of a treatment for this indication.

Compounding 118

Compounding 118

Pharma Times

SEPTEMBER 15, 2023

The site will contribute to the development and commercialisation of antibody drugs - News - PharmaTimes

140

140

European Pharmaceutical Review

SEPTEMBER 15, 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson has changed its name to Johnson & Johnson Innovative Medicine (J&J Innovative Medicine). Johnson & Johnson is bringing together its divisions under the J&J brand name. While Janssen, J&J’s pharmaceutical division will be known as J&J Innovative Medicine, the company’s medical technology segment will continue to be named Johnson & Johnson MedTech.

Chemotherapy 93

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Packaging 93

Pharma Times

SEPTEMBER 15, 2023

The method could also be beneficial for Parkinson’s disease and strokes - News - PharmaTimes

136

136

The Pharmacist

SEPTEMBER 15, 2023

A recent initiative to prevent suicide among healthcare workers only supports pharmacists employed by the NHS and does not currently extend to community pharmacists, a mental health charity has warned. Pharmacist Support said that while it welcomed the new toolkit published by NHS England (NHSE) earlier this month, community pharmacists were also ‘in great need […] The post Community pharmacists ‘in great need’ of suicide prevention support appeared first on The Pharmacist.

98

98

Pharmaceutical Technology

SEPTEMBER 15, 2023

The company is also planning to expand its Phase I/II PRODYGY lead candidate trial in retinitis pigmentosa to three more US sites.

105

105

pharmaphorum

SEPTEMBER 15, 2023

FTC fires shot across pharma's bows over 'improper' patents Phil.

136

136

Pharmaceutical Technology

SEPTEMBER 15, 2023

Cure Genetics has entered a partnership and licensing deal with Frametact to develop gene therapy for familial neurological ailments.

98

98

Pharmaceutical Commerce

SEPTEMBER 15, 2023

Protective case manufacturer hires James Curleigh, as company prepares to further innovation and expand.

105

105

The Pharmacist

SEPTEMBER 15, 2023

Fresh calls have been made for long-term funding for community pharmacy after the sector appeared to be excluded from the government’s latest winter funding package for the NHS. Following a meeting with healthcare leaders earlier this week, the Department of Health and Social Care (DHSC) announced a £200m funding package to help ‘boost NHS resilience’ […] The post NHS winter funding ‘would be better invested in long-term planning for community’ appeared first on The Pharmacist.

Community Pharmacies 82

Community Pharmacies Packaging 82

Drug Channels

SEPTEMBER 15, 2023

Today’s guest post comes from Nicole Mayer, Senior Analyst at MMIT. Nicole summarizes MMIT’s research on payers’ views of two crucial market changes: (1) the Inflation Reduction Act of 2022’s requirement to cap insulin prices at $35 for Medicare beneficiaries, and (2) manufacturers’ reduction in list prices for certain insulin products. She also discusses MMIT’s research on such glucagon-like peptide 1 (GLP-1) drugs as Ozempic and Mounjaro.

71

71

pharmaphorum

SEPTEMBER 15, 2023

Scientists find elusive cause of cell death in Alzheimer's Phil.

117

117

World Pharma News

SEPTEMBER 15, 2023

Cells are capable of translating mechanical changes into biological responses. This process is known as mechanotransduction and plays a fundamental role in the progression of solid tumors, such as breast cancer. It is well-established that a common mechanical alteration in cancer progression involves tissue hardening.

73

73

pharmaphorum

SEPTEMBER 15, 2023

Driving data & analytics transformation in life sciences Mike.

116

116

Big Molecule Watch

SEPTEMBER 15, 2023

On September 6, 2023, the Association for Accessible Medicines (AAM) released its 2023 U.S. Generic & Biosimilar Medicines Savings Report highlighting the significant economic contributions of generic and biosimilar medicines. Notably, the U.S. healthcare system, including patients, employers and taxpayers, saved $408 billion in 2022 by using FDA-approved generic and biosimilar drugs, per the AAM’s report.

Biosimilars 67

Biosimilars Prescription Filling 67

FDA Law Blog: Biosimilars

SEPTEMBER 15, 2023

On September 18-20, Informa Connect will hold its annual #MDRPSummit in Chicago (and via livestream) to discuss the complex, ever-evolving laws and regulations in the government pricing and price reporting space. This three-day summit will feature numerous presentations, workshops and networking opportunities featuring government officials, drug pricing and reimbursement lawyers and experts and industry leaders.

Drug Pricing 64

Drug Pricing 64

BioPharma Dive

SEPTEMBER 15, 2023

The antitrust regulator is examining what it describes as abuse of the FDA “Orange Book” — another step in its scrutiny of pharma business practices.

65

65

pharmaphorum

SEPTEMBER 15, 2023

FDA capacity forces delay to Iovance's cell therapy Phil.

104

104

Drug Patent Watch

SEPTEMBER 15, 2023

Annual Drug Patent Expirations for INGREZZA Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are twenty patents protecting… The post New patent for Neurocrine drug INGREZZA appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Putting Patients First Blog

SEPTEMBER 15, 2023

After three-quarters of a century of mission work, the National Hemophilia Foundation has changed its name September 15, 2023 By: Serena Crawford, MMC, National Bleeding Disorder Foundation After 75 years of being known as the National Hemophilia Foundation (NHF), the organization has changed its name to the National Bleeding Disorders Foundation (NBDF).

Communication 59

Communication 59

Drug Patent Watch

SEPTEMBER 15, 2023

Annual Drug Patent Expirations for SUNOSI Sunosi is a drug marketed by Axsome Malta and is included in one NDA. It is available from two suppliers. There are thirteen patents… The post New patent for Axsome Malta drug SUNOSI appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Syner-G

SEPTEMBER 15, 2023

Developing biologics can be challenging. Their development protocols are significantly different from small molecule drugs, which provide a general response and comprise as much as 90% of the pharmaceutical drug market. Biologics are more complex, though, with targeted mechanisms and potent pharmacological impacts. Nonetheless, their rising popularity – eight of the top 10 best-selling drugs internationally in 2016 were biologics – underscores their increasing importance. 5 Key Steps in Large Mo

Drug Development 59

Drug Development Documentation Process Improvement Compounding 59

Drug Patent Watch

SEPTEMBER 15, 2023

Annual Drug Patent Expirations for AUVELITY Auvelity is a drug marketed by Axsome and is included in one NDA. It is available from one supplier. There are one hundred and… The post New patent for Axsome drug AUVELITY appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Pharmafile

SEPTEMBER 15, 2023

Bristol Myers Squibb (BMS) recently held a Research and Development (R&D) Day in New York, US, in order to discuss the company’s R&D strategy and capabilities while providing insights into its pipeline and long-term growth plans. The company’s leadership team discussed its differentiated research platforms and R&D framework, which are intended to drive productivity, deliver […] The post BMS shares new research and development plans at the company’s R&D day appeared first

58

58

Drug Patent Watch

SEPTEMBER 15, 2023

Annual Drug Patent Expirations for FERRIPROX Ferriprox is a drug marketed by Chiesi and is included in three NDAs. It is available from two suppliers. There are six patents protecting… The post New patent for Chiesi drug FERRIPROX appeared first on DrugPatentWatch - Make Better Decisions.

59

59